Keller J, Ringseis R, Koc A, Lukas I, Kluge H, Eder K
It should also be noted that, from a methodological perspective, the model used (Cox with stratification by cardiovascular risk class of the trials, i.e., SURPASS-4: high risk, and all others: low risk) requires various assumptions, including the homogeneity of the relative effect of tirzepatide treatment on MACE regardless of the baseline cardiovascular risk level of the patients
The body has had 12+ weeks to adapt to amylin signaling
These are some possible biological plausibilities of a connection: Chronic or even low-dose Tylenol use during pregnancy could deplete glutathione
Whatever system you use, tracking your sites in a journal, calendar, or notes app helps prevent accidentally repeating a spot too soon
10.1016/s0022-3476(94)70309-4 20